Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications

Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment: Third Edition

Volumn , Issue , 2015, Pages 27-58

  Malm, Heli ^a   Borisch, Cornelia ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acetaminophen; ASA; Fever; Migraine; NSAIDs; Opiates; Pain; Paracetamol

Indexed keywords

EID: 84943257562     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-408078-2.00002-0     Document Type: Chapter

References (182)

1. Alano M.A., Ngougmna E., Osrea E.M., et al Analysis of antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 2001, 107:519-523.
2. Alexander F.E., Patheal S.L., Biondi A., et al Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 2001, 61:2542-2546.
3. Esa W Ali Sakr, Toma I., Tetzlaff J.E., et al Epidural analgesia in labor for a woman with an intrathecal baclofen pump. Int J Obst Anesth 2009, 18:64-66.
4. Amin S.B., Sinkin R.A., Glantz J.C. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol 2007, 197(486):e1-10.
5. Antonucci R., Cuzzolin L., Arceri A., et al Urinary prostaglandin E2 in the newborn and infant. Prostag Oth Lipid M 2007, 84:1-13.
6. Antonucci R., Zaffanello M., Puxeddu E., et al Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab 2012, 13:474-490.
7. Aranda M.A., Herranz A., del Val J., et al Botulinum toxin A during pregnancy, still a debate. Eur J Neurol 2012, 19:e81-e82.
8. Asali L.A., Brown K.F. Naloxone protein binding in adult and foetal plasma. Eur J Clin Pharmacol 1984, 27:459-463.
9. Bakkeheim E., Mowinckel P., Carlsen K.H., et al Paracetamol in early infancy: the risk of childhood allergy and asthma. Acta Paediatr 2011, 100:90-96.
10. Balasubramaniam J. Nimesulide and neonatal renal failure. Lancet 2000, 355:575. Scopus Exact.
11. Bar-Oz B., Clementi M., Di Giantonio E., et al Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study. Eur J Obstet Gynecol Reprod Biol 2005, 119:176-179. Scopus Exact.
12. Bates S.M., Greer I.A., Middeldorp S., et al VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141:e691S-e736S.
13. Ben-Chetrit E., Ben-Chetrit A., Berkun Y., et al Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified?. Arthritis Care Res 2010, 62:143-148.
14. Ben-Chetrit E., Berkun Y., Ben-Chetrit E., et al The outcome of pregnancy in the wives of men with familial mediterranean fever treated with colchicine. Semin Arthritis Rheum 2004, 34:549-552.
15. Benini D., Fanos V., Cuzzolin L., et al In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol 2004, 19:232-234. Berlin.
16. Bérard A., Kori S. Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes. Headache 2012, 52:1085-1093.
17. Berkenstadt M., Weisz B., Cuckle H., et al Chromosomal abnormalities and birth defects among couples with colchicine treated familial Mediterranean fever. Am J Obstet Gynecol 2005, 193:1513-1516.
18. Bio L.L., Siu A., Poon C.Y. Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol 2011, 31:692-701.
19. Bloor M., Paech M.J., Kaye R. Tramadol in pregnancy and lactation. Int J Obstet Anesth 2012, 21:163-167.
20. Bolisetty S., Kitchanan S., Whitehall J. Generalized muscle rigidity in a neonate following intrathecal fentanyl during caesarean delivery. Intensive Care Med 1999, 25:1337.
21. Borna S., Saeidi F.M. Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial. J Obstet Gynaecol Res 2007, 33:631-634.
22. Boubred F., Vendemmia M., Garcia-Meric P., et al Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf 2006, 29:397-419.
23. Bracken M.B., Holford T.R. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 1981, 58:336-344. Refrository Exact.
24. Brandlistuen R.E., Ystrom E., Nulman I., et al Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol 2013, 42:1702-1713.
25. Broussard C.S., Rasmussen S.A., Reefhuis J. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011, 204:314.
26. Bujold E., Roberge S., Lacasse Y., et al Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010, 116:402-414.
27. Butler-O'Hara M., D'Angio C.T. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor. J Perinatol 2002, 22:541-546.
28. Capogna G., Camorcia M. Epidural analgesia for childbirth: effects of newer techniques on neonatal outcome. Paediatr Drugs 2004, 6:375-386.
29. Cappon G.D., Cook J.C., Hurtt M.E. Relationship between cyclooxygenase (COX) 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure. Birth Defects Res B 2003, 68:47-56.
30. Cartwright D.P., Dann W.L., Hutchinson A. Placental transfer of alfentanil at caesarean section. Eur J Anaesthesiol 1989, 6:103-109.
31. Cassina M., De Santis M., Cesari E., et al First trimester diclofenac exposure and pregnancy outcome. Reprod Toxicol 2010, 30:401-404.
32. Catalan J.L., Santonja J., Martinze L., et al Oligoamnios associated with the use of magnesium dipyrone. Med Clin (Barc) 1995, 104:541-543.
33. Chasnoff I.J., Hatcher R., Burns W.J. Pentazocine and tripelennamine (T's and blue's): effects on the fetus and neonate. Devel Pharmacol Ther 1983, 6:162-169.
34. Chen H.M., Chen S.F., Chen Y.H., et al Increased risk of adverse pregnancy outcomes for women with migraines: a nationwide population-based study. Cephalalgia 2010, 30:433-438.
35. Claahsen-van der Grinten H.L., Verbruggen I., van den Berg P.P., et al Different pharmacokinetics of tramadol in mothers treated for labour pain and in their neonates. Eur J Clin Pharmacol 2005, 61:523-529.
36. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994, 343:619-629. CLASP Collaborative Group.
37. Collins L.R., Hall R.W., Dajani N.K., et al Prolonged morphine exposure in utero causes fetal and placental vasoconstriction: a case report. J Matern Fetal Neonat Med 2005, 17:417-421.
38. Cooper J., Jauniaux E., Gulbis B., et al Placental transfer of fentanyl in early human pregnancy and its detection in fetal brain. Br J Anaesth 1999, 82:929-931.
39. Czeizel A. Teratogenicity of ergotamine. J Med Genet 1989, 26:69-70.
40. Cunnington M., Ephross S., Churchill P. The safety of sumatriptan and naratriptan in pregnancy: what have we learned?. Headache 2009, 49:1414-1422.
41. Dalton C.M., Keenan E., Jarrett L., et al The safety of baclofen in pregnancy: intrathecal therapy in multiple sclerosis. Mult Scler 2008, 14:571-572.
42. Daniel S., Matok I., Gorodischer R., et al Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy. J Rheumatol 2012, 39:2163-2169.
43. da Silva Dal Pizzol T., Schüler-Faccini L., Mengue S.S. Dipyrone use during pregnancy and adverse perinatal events. Arch Gynecol Obstet 2009, 279:293-297.
44. DeBooy V.D., Seshia M.M., Tenenbein M., et al Intravenous pentazocine and methylphenidate abuse during pregnancy. Maternal lifestyle and infant outcome. Am J Dis Child 1993, 147:1062-1065.
45. Diav-Citrin O., Shechtman S., Schwartz V. Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol 2010, 203(144):e1-e6.
46. Dinchuk J.E., Car B.D., Focht R.J., et al Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995, 378:406-409.
47. Draper E.S., Rankin J., Tonks A.M., et al Recreational drug use: a major risk factor for gastroschisis?. Am J Epidemiol 2008, 167:485-491.
48. Ebner N., Rohrmeister K., Winklbaur B., et al Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007, 87:131-138.
49. Einarson A., Bozzo P., Taguchi N. Use of a fentanyl patch throughout pregnancy. J Obstet Gynaecol Canada 2009, 31:20.
50. Ericson A., Källén B.A.J. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 2001, 15:371-375.
51. Eventov-Friedman S., Rozin I., Shinwell E.S. Case of chest-wall rigidity in a preterm infant caused by prenatal fentanyl administration. J Perinatol 2010, 30:149-150.
52. Eyers S., Weatherall M., Jefferies S., et al Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy 2011, 41:482-489.
53. Facchinetti F., Allais G., Nappi R.E., et al Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia 2009, 29:286-292.
54. Feldkamp M.L., Meyer R.E., Krikov S., et al Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study. Obstet Gynecol 2010, 115:109-115.
55. Fujii T., Nishimura H. Comparison of teratogenic action of substances related to purine metabolism in mouse embryos. Jpn J Pharmacol 1972, 22:201-206.
56. Garcia-Marcos L., Sanchez-Solis M., Perez-Fernandez V., et al Is the effect of prenatal paracetamol exposure on wheezing in preschool children modified by asthma in the mother?. Int Arch Allergy Immunol 2009, 149:33-37.
57. Geber W.F., Schramm L.C. Congenital malformations of the central nervous system produced by narcotic analgesics in the hamster. Am J Obstet Gynecol 1975, 123:705-713.
58. Gewillig M., Brown S.C., De Catte L., et al Premature foetal closure of the arterial duct: clinical presentations and outcome. Eur Heart J 2009, 30:1530-1536.
59. Graf W.D., Shepard T.H. Uterine contraction in the development of Möbius syndrome. J Child Neurol 1997, 12:225-227.
60. Groeneveld E., Lambers M.J., Lambalk C.B., et al Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: a meta-analysis with individual patient data. Hum Reprod 2013, 28:1480-1488.
61. Gupta C., Bentlejewski C.A. Role of prostaglandins in the testosterone-dependent Wolffian duct differentiation of the fetal mouse. Biol Reprod 1992, 47:1151-1160.
62. Hartenstein S., Proquitté H., Bauer S., et al Neonatal abstinence syndrome (NAS) after intrauterine exposure to tramadol. J Perinat Med 2010, 38:695-696.
63. Heinonen O.P., Slone D., Shapiro S. Birth Defects and Drugs in Pregnancy 1977, Publishing Sciences Group, Littleton.
64. Henderson A.J., Shaheen S.O. Acetaminophen and asthma. Paediatr Resp Rev 2013, 14:9-15.
65. Hernandez R.K., Werler M.M., Romitti P., et al Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol 2012, 206:228.
66. Herschel M., Khoshnood B., Lass N.A. Role of naloxone in newborn resuscitation. Pediatrics 2000, 106:831-835.
67. Hoeltzenbein M., Stieler K., Panse M., et al Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity. PLoS One 2013, 8:e66637.
68. Holmes R.P., Stone P.R. Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. Obstet Gynecol 2000, 96:810-811.
69. Hughes H.E., Goldstein D.A. Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine. J Med Genet 1988, 25:396-399.
70. Humphrey R.G., Bartfield M.C., Carlan S.J., et al Sulindac to prevent recurrent preterm labor: a randomized controlled trial. Obstet Gynecol 2001, 98:555-562.
71. Itabashi K., Ohno T., Nishida H. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. J Pediatr 2003, 143:203-207.
72. Jayagopal N., Sinha D., Bhatti N.R. Use of sulindac in polyhydramnios. J Obstet Gynaecol 2007, 27:850.
73. Jensen M.S., Rebordosa C., Thulstrup A.M., et al Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology 2010, 21:779-785.
74. Kaandorp S.P., Goddijn M., van der Post J.A., et al Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010, 362:1586-1596.
75. Kaandorp J.J., Benders M.J., Rademaker C.M., et al Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth 2010, 10:8.
76. Keeling D., Mackie I., Moore G.W., et al Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012, 157:47-58.
77. Källén B.A., Nilsson E., Otterblad Olausson P. Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. Drug Saf 2011, 34:691-703.
78. Källén B.A., Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003, 17:255-261.
79. Kang E.M., Lundsberg L.S., Illuzzi J.L., et al Prenatal exposure to acetaminophen and asthma in children. Obstet Gynecol 2009, 114:1295-1306.
80. Koklu E., Gurgoze M., Akgun H., et al Renal tubular dysgenesis with atypical histology and in-utero exposure to naproxen sodium. Ann Trop Paediatr 2006, 26:241-245.
81. Kopecky E.A., Ryan M.L., Barrett J.F.R., et al Fetal response to maternally administered morphine. Am J Obstet Gynecol 2000, 183:424-430.
82. Kozenko M., Grynspan D., Oluyomi-Obi T., et al Potential teratogenic effects of allopurinol: a case report. Am J Med Genet A 2011, 155:2247-2252.
83. Kozer E., Nikfar S., Costei A., et al Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002, 187:1623-1630.
84. Kristensen D.M., Hass U., Lesné L., et al Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 2011, 26:235-244.
85. Li D.K., Liu L., Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003, 327:1-5.
86. Liew Z., Ritz B., Rebordosa C., et al Acetaminophen Use During Pregnancy, Behavioral Problems, and Hyperkinetic Disorders. JAMA Pediatr 2014, Published online Feb 24. 10.1001/jamapediatrics.2013.4914.
87. Lindemann R. Respiratory muscle rigidity in a preterm infant after use of fentanyl during Caesarean section. Eur J Pediatr 1998, 157:1012-1013.
88. Little B.B., Snell L.M., Breckenridge J.D., et al Effects of T's and blues abuse on pregnancy outcome and infant health status. Am J Perinatol 1990, 7:359-362.
89. Loftus J.R., Hill H., Cohen S.E. Placental transfer and neonatal effects of epidural sufentanil and fentanyl administered with bupivacaine during labor. Anesthesiology 1995, 83:300-308.
90. Loudon J.A., Groom K.M., Bennett P.R. Prostaglandin inhibitors in preterm labour. Best Pract Res Clin Obstet Gynaecol 2003, 17:731-744.
91. Mac Bird T., Robbins J.M., Druschel C., et al Demographic and environmental risk factors for gastroschisis and omphalocele in the National Birth Defects Prevention Study. J Pediatr Surg 2009, 44:1546-1551.
92. Madry H., Grün U.W., Knutsen G. Cartilage repair and joint preservation: medical and surgical treatment options. Dtsch Ärztebl Int 2011, 108:669-677.
93. Magnani C., Moretti S., Ammenti A. Neonatal chronic failure associated with maternal ingestion of nimesulide as analgesic. Eur J Obstet Gynaecol Reprod Biol 2004, 116:244-245.
94. Marcus D.A., Scharff L., Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999, 39:625-632.
95. Marret S., Marchand L., Kaminski M., et al Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm. Pediatrics 2010, 125:e29-e34.
96. Martinez-Frias M.L., Rodriguez-Pinilla E., Prieto L. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 1997, 56:241-243.
97. McGinnis W.R., Audhya T., Edelson S.M. Proposed toxic and hypoxic impairment of a brainstem locus in autism. Int J Environ Res Public Health 2013, 10:6955-7000.
98. McNamee K., Dawood F., Farquharson R. Recurrent miscarriage and thrombophilia: an update. Curr Opin Obstet Gynecol 2012, 24:229-234.
99. Medveczky E., Puhó E., Czeizel E.A. The use of drugs in mothers of offspring with neural-tube defects. Pharmacoepidemiol Drug Saf 2004, 13:443-455.
100. Meyer F.P., Rimasch H., Blaha B., et al Tramadol withdrawal in a neonate. Eur J Clin Pharmacol 1997, 53:159-160.
101. Micu M.C., Micu R., Ostensen M. Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. Arthritis Care Res (Hoboken) 2011, 63:1334-1338.
102. Miller E.A., Rasmussen S.A., Siega-Riz A.M., et al Risk factors for non-syndromic holoprosencephaly in the National Birth Defects Prevention Study. Am J Med Genet C Semin Med Gen 2010, 154C:62-72.
103. Moise K.J., Huhta J.C., Sharif D.S., et al Indomethacin in the treatment of premature labor, effects on the fetal ductus arteriosus. N Engl J Med 1988, 319:327-331.
104. Moise K.J., Ou C.N., Kirshon B., et al Placental transfer of indomethacin in the human pregnancy. Am J Obstet Gynecol 1990, 162:549-554.
105. Moise K.J. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol 1993, 168:1350-1353.
106. Moran L.R., Almeida P.G., Worden S., et al Intrauterine baclofen exposure: a multidisciplinary approach. Pediatrics 2004, 114:e267-e269.
107. Morley-Forster P.K., Reid D.W., Vandeberghe H. A comparison of patient-controlled analgesia fentanyl and alfentanil for labour analgesia. Can J Anaesth 2000, 47:113-119.
108. Morrison C.E., Dutton D., Howie H., et al Pethidine compared with meptazinol during labour. Anaesthesia 1987, 42:7-14.
109. Munoz F.C., Marco D.G. Pregnancy outcome in a woman exposed to continuous intrathecal baclofen infusion. Ann Pharmacother 2000, 34:956.
110. Nezvalová-Henriksen K., Spigset O., Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 2010, 50:563-575.
111. Nezvalová-Henriksen K., Spigset O., Nordeng H. Effects of codeine on pregnancy outcome: results from a large population-based cohort study. Eur J Clin Pharmacol 2011, 67:1253-1261.
112. Nezvalová-Henriksen K., Spigset O., Nordeng H.M. Erratum to: Effects of codeine on pregnancy outcome: results from a large population-based cohort study. Eur J Clin Pharmacol 2012, 68:1689-1690.
113. Nezvalová-Henriksen K., Spigset O., Nordeng H.M. Errata in: Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian mother and child cohort study. Headache 2012, 52:1319-1320.
114. Nezvalová-Henriksen K., Spigset O., Nordeng H. Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. Br J Obstet Gynaecol 2013, 120:948-959.
115. Nezvalová-Henriksen K., Spigset O., Nordeng H. Triptan safety during pregnancy: a Norwegian population registry study. Eur J Epidemiol 2013, 28:759-769.
116. Nikkola E.M., Jahnukainen T.J., Ekblad U.U., et al Neonatal monitoring after maternal fentanyl analgesia in labor. J Clin Monit Comput 2000, 16:597-608.
117. Norwood V.F., Morham S.G., Smithies O. Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice. Kidney Int 2000, 58:2291-2300. Refrository Exact.
118. Nuttall S.L., Khan J.N., Thorpe G.H., et al The impact of therapeutic doses of paracetamol on serum total antioxidant capacity. J Clin Pharm Ther 2003, 28:289-294.
119. Oberlander T.F., Robeson P., Ward V., et al Prenatal and breast milk morphine exposure following maternal intrathecal morphine treatment. J Hum Lact 2000, 16:137-142.
120. Ofori B., Oraichi D., Blais L., et al Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol 2006, 77:268-279.
121. Ognjanovic S., Blair C., Spector L.G., et al Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group study. Br J Cancer 2011, 104:532-536.
122. O'Mara K., Gal P., Davanzo C. Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol. Ann Pharmacother 2010, 44:1342-1344.
123. Østensen M.E., Skomsvoll J.F. Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 2004, 5:571-580.
124. Paladini D., Marasini M., Volpe P. Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide. Ultrasound Obstet Gynecol 2005, 25:357-361.
125. Peruzzi L., Gianoglio B., Porcellini M.G., et al Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type I selective inhibitor nimesulide as tocolytic. Lancet 1999, 354:1615.
126. Perzanowski M.S., Miller R.L., Tang D., et al Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort. Thorax 2010, 65:118-123.
127. Pombo-de-Oliveira M.S., Koifman S. Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 2006, 15:2336-2341.
128. Prefumo F., Marasini M., de Biasio P., et al Acute premature constriction of the ductus arteriosus after maternal self-medication with nimesulide. Fetal Diagn Ther 2008, 24:35-38.
129. Ratnayaka B.D.M., Dhaliwal H., Watkin S. Neonatal convulsions after withdrawal of baclofen. Br Med J 2001, 323:85.
130. Rayburn W., Rathke A., Leuschen M.P., et al Fentanyl citrate analgesia during labor. Am J Obstet Gynecol 1989, 161:202-206.
131. Rebordosa C., Kogevinas M., Sørensen H.T., et al Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: a birth cohort study. Int J Epidemiol 2008, 37:583-590.
132. Rebordosa C., Zelop C.M., Kogevinas M., et al Use of acetaminophen during pregnancy and risk of preeclampsia, hypertensive and vascular disorders: a birth cohort study. J Matern Fetal Neonat Med 2010, 23:371-378.
133. Regan J., Chambers F., Gorman W., et al Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. Br J Obstet Gynaecol 2000, 107:570-572.
134. Reynolds F. The effects of maternal labour analgesia on the fetus. Best Pract Res Clin Obstet Gynaecol 2010, 24:289-302.
135. Reynolds F. Labour analgesia and the baby: good news is no news. Int J Obstet Anesth 2011, 20:38-50.
136. Roberge S., Giguère Y., Villa P., et al Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 2012, 29:551-556.
137. Roberts A.G., Graves C.R., Konrad P.E., et al Intrathecal baclofen pump implantation during pregnancy. Neurology 2003, 61:1156.
138. Roberts I., Robinson M.J., Mughal M.Z., et al Paracetamol metabolites in the neonate following maternal overdose. Br J Clin Pharmacol 1984, 18:201-206.
139. Robin Y.M., Reynaud P., Orliaguet T., et al Renal tubular dysgenesis-like lesions and hypocalvaria. Report of two cases involving indomethacin. Pathol Res Pract 2000, 196:791-794.
140. Rode L., Bundgaard A., Skibsted L., et al Acute recurrent polyhydramnios: a combination of amniocenteses and NSAID may be curative rather than palliative. Fetal Diagn Ther 2007, 22:186-189.
141. Rothman K.J., Fyler D.C., Goldblatt A., et al Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol 1979, 109:433-439.
142. Salmaso N., Tomasi S., Vaccarino F.M. Neurogenesis and Maturation in Neonatal Brain Injury. Clin Perinatol 2014, 41:229-239.
143. Sances G., Granella F., Nappi R., et al Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003, 23:197-205.
144. Sawdy R.J., Lye S., Fisk N.M., et al A double-blind randomized study of fetal side effects during and after short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labour. Am J Obstet Gynecol 2003, 188:1046-1051.
145. Sawdy R.J., Groom K.M., Bennett P.R. Experience of the use of nimesulide, a cyclo-oxygenase-2 selective prostaglandin synthesis inhibitor, in the prevention of preterm labour in 44 high-risk cases. J Obstet Gynaecol 2004, 24:226-229.
146. Saxén I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 1975, 4:37-44.
147. Schick B., Hom M., Tolosa J., et al Preliminary analysis of first trimester exposure to oxycodone and hydrocodone. Reprod Toxicol 1996, 10:162. {Abstract}.
148. Scialli A.R., Ang R., Breitmeyer J., et al A review of the literature on the effects of acetaminophen on pregnancy outcome. Reprod Toxicol 2010, 30:495-507.
149. Scialli A.R., Ang R., Breitmeyer J., et al Childhood asthma and use during pregnancy of acetaminophen. A critical review. Reprod Toxicol 2010, 30:508-519.
150. Shaheen S.O., Newson R.B., Sherriff A., et al Paracetamol use in pregnancy and wheezing in early childhood. Thorax 2002, 57:958-963.
151. Shannon C., Jauniaux E., Gulbis B., et al Placental transfer of fentanyl in early human pregnancy. Hum Reprod 1998, 13:2317-2320.
152. Sharpe C.R., Franco E.L. Use of dipyrone during pregnancy and risk of Wilms' tumor. Brazilian Wilms' Tumor Study Group. Epidemiology 1996, 7:533-535.
153. Shaw G.M., Malcoe L.H., Swan S.H., et al Congenital cardiac anomalies relative to selected maternal exposures and conditions during early pregnancy. Eur J Epidemiol 1992, 8:757-760.
154. Shaw G.M., Todoroff K., Velie E.M., et al Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 1998, 57:1-7.
155. Siu K.L., Lee W.H. Maternal diclofenac sodium ingestion and severe neonatal pulmonary hypertension. J Paediatr Child Health 2004, 40:152-153.
156. Siu S.S.N., Yeung J.H.K., Lau T.K. A study on placental transfer of diclofenac in first trimester of human pregnancy. Hum Reprod 2000, 15:2423-2425.
157. Sivojelezova A., Koren G., Einarson A. Glucosamine use in pregnancy: an evaluation of pregnancy outcome. J Womens Health (Larchmt) 2007, 16:345-348.
158. Smets K., Zecic A., Willems J. Ergotamine as a possible cause of Möbius sequence: additional clinical observation. J Child Neurol 2004, 19:398.
159. Snijder C.A., Kortenkamp A., Steegers E.A., et al Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study. Hum Reprod 2012, 27:1191-1201.
160. Sood B.G., Lulic-Botica M., Holzhausen K.A., et al The risk of necrotizing enterocolitis after indomethacin tocolysis. Pediatrics 2011, 128:e54-e62.
161. Sosa C.G., Buekens P., Hughes J.M., et al Effect of pethidine administered during the first stage of labor on the acid-base status at birth. Eur J Obstet Gynecol Reprod Biol 2006, 129:135-139.
162. Steinmeyer J., Konttinen Y.T. Oral treatment options for degenerative joint disease - presence and future. Adv Drug Deliv Rev 2006, 58:168-211.
163. Stika C.S., Gross G.A., Leguizamon G., et al A prospective randomized safety trial of celecoxib for treatment of preterm labour. Am J Obstet Gynecol 2002, 187:653-660.
164. Suzumori N., Hattori Y., Kaneko S., et al Cytomegalovirus-associated acute hydramnios treated by amniocentesis and maternal indomethacin. Congenit Anom (Kyoto) 2009, 49:274-275.
165. Talati A.J., Salim M.A., Korones S.B. Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report. Am J Perinatol 2000, 17:69-71.
166. Torfs C.P., Katz E.A., Bateson T.F., et al Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 1996, 54:84-92.
167. Torloni M.R., Cordioli E., Zamith M.M. Reversible constriction of the fetal ductus arteriosus after maternal use of topical diclofenac and methyl salicylate. Ultrasound Obstet Gynecol 2006, 27:227-229.
168. Ullman R., Smith L.A., Burns E. Parenteral opioids for maternal pain relief in labour. Cochrane Database Syst Rev 2010, 8. CD007396.
169. Van de Velde M., Vercauteren M., Vandermeersch E. Fetal heart rate abnormalities after regional analgesia for labor pain: the effect of intrathecal opioids. Reg Anaesth Pain Med 2001, 26:257-262.
170. Van de Velde M., Teunkens A., Hanssens M., et al Intrathecal sufentanil and fetal heart rate abnormalities: a double-blind, double placebo-controlled trial comparing two forms of combined spinal epidural analgesia with epidural analgesia in labor. Anesth Analg 2004, 98:1153-1159.
171. Van den Veyver I.B., Moise K.J., Ou C.N., et al The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus. Obstet Gynecol 1993, 82:500-503.
172. Van der Heijden B.J., Carlus C., Narcy F., et al Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol 1994, 171:617-623.
173. Van der Heijden B., Gubler M.C. Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents. Pediatr Nephrol (Berlin) 1995, 9:675.
174. Van Marter L.J., Leviton A., Allred E.N. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 1996, 97:658-663.
175. Van Marter L.J., Hernandez-Diaz S., Werler M.M., et al Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn. Pediatrics 2013, 131:79-87.
176. Weintraub A., Mankuta D. Dipyrone-induced oligohydramnios and ductus arteriosus restriction. Isr Medic Assoc J 2006, 8:722-723.
177. Welsh M., Saunders P.T., Fisken M., et al Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 2008, 118:1479-1490.
178. Werler M.M., Sheehan J.E., Mitchell A.A. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 2002, 155:26-31.
179. Werler M.M., Mitchell A.A., Moore C.A., et al Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis?. Am J Med Genet A 2009, 149A:1399-1406.
180. Werler M.M., Bosco J.L., Shapira S.K., et al Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects. Birth Defects Res A Clin Mol Teratol 2009, 85:52-57.
181. Willaschek C., Wolter E., Buchhorn R. Tramadol withdrawal in a neonate after long-term analgesic treatment of the mother. Eur J Clin Pharmacol 2009, 65:429-430.
182. Zenker M., Klinge J., Krüger C., et al Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report. J Perinat Med 1998, 26:231-234.